NOS3 and myocardial infarction: After MI, cardiac levels of total eNOS and phosphorylated eNOS were decreased, whereas exendin-4 treatment increased the eNOS and p-eNOS expression and inhibited the Ca2+/calmodulin-dependent kinase II pathways [21].